Truist Securities Maintains Buy on AdaptHealth, Lowers Price Target to $14
Portfolio Pulse from Benzinga Newsdesk
Truist Securities analyst David Macdonald has maintained a 'Buy' rating on AdaptHealth (NASDAQ:AHCO), but lowered the price target from $18 to $14.

October 11, 2023 | 8:02 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
AdaptHealth's price target has been lowered from $18 to $14 by Truist Securities, though the 'Buy' rating is maintained.
The lowering of the price target by Truist Securities could potentially create a negative sentiment among investors, which might put downward pressure on the stock price. However, the maintained 'Buy' rating indicates that the analyst still sees potential in the company, which could offset the negative impact to some extent.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100